Edesa Biotech, Inc.
NASDAQ:EDSA · NASDAQ Capital Market
+$0.09 today
Vol 0.25M · Avg 0.62M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+267.50%
Period High
$18.27
Period Low
$0.80
Latest
$7.35
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Sensei Biotherapeutics, Inc.
SNSE
$18.59M
Cocrystal Pharma, Inc.
COCP
$10.09M
OSR Holdings, Inc.
OSRH
$9.43M
Traws Pharma, Inc.
TRAW
$7.01M
Immuron Limited
IMRN
$6.80M
Imunon, Inc.
IMNN
$4.77M
Evogene Ltd.
EVGN
$4.40M
BioRestorative Therapies, Inc.
BRTX
$3.54M
Dogwood Therapeutics, Inc.
DWTX
$2.81M
Ernexa Therapeutics Inc.
ERNA
$1.82M
What is the latest EDSA filing?
The latest filing shown is SC 13D/A dated Jun 16, 2026.
How many recent filings does EDSA have?
Intrinsic Alpha currently shows 20 recent filings for EDSA.
Explore More
Continue the stock analysis
Jump to another research area for this company.